Archives of Medicine

  • ISSN: 1989-5216
  • Journal h-index: 17
  • Journal CiteScore: 4.25
  • Journal Impact Factor: 3.58
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


Lipid Profile among Art Treated and Untreated Patients in HIV Positive Cases

Doddigarla Zephy, Lingidi Jhansi Lakshmi and Raghib Ashraff

HAART treated or untreated HIV Seropositive cases have dyslipidaemia. In untreated HIV infection, most of the ATP is used in the reverse transcription process in attaining morphism of the host cell. The aim of the study was to find the lipid profile pattern in treated HIV patients after shorter period of time with ART (First line of treatment i.e. zidovudine, lamuvudine and Nevirapine) and comparing them against HIV infected untreated individuals and controls within our locality. Subject field of HIV Seropositive cases (n=84) and age and sex matched healthy non-HIV cases as controls (n=47). Comparison between the HIV infected (n=42), HIV infected ART treated (n=42) and controls were significant (p 0.000) for fasting cholesterol, triacylglycerols (p 0.000) and HDLc (p 0.000) and LDLc (p 0.000). Insignificant when TAG compared controls to HIV infected ART untreated subjects. Statistical significance in between sexes within untreated patients' lipid profile in HDLc (35 ± 3.8 against 37.4 ± 3.5) and LDLc (48.0 ± 8.3 against 38.0 ± 7.2). Patients infected with HIV, constantly screened for lipid abnormalities when ART treated or untreated and carefully prescribe an anti retroviral treatment regime which will undeniably support in supervision of dyslipidaemia in HIV seropositive patients in future.